#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15434	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2049	745.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1696	1696	T	848	T,C	782,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15434	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2049	745.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	912	C,A	856,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3782	729.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1786	1786	A	911	A,G	848,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3782	729.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2420	2420	C	859	C,T	811,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3782	729.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2494	2494	A	885	A	832	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3782	729.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3046	3046	C	858	C,T	802,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2164	folP	855	855	100.0	folP.l15.c17.ctg.1	1393	153.2	1	SNP	p	R229S	1	.	.	685	687	AGC	957	959	AGC	237;236;238	A;G;C	220;219;219	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5680	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3483	162.6	1	SNP	p	S91F	1	.	.	271	273	TTC	569	571	TTC	180;181;179	T;T;C	171;174;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5680	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3483	162.6	1	SNP	p	D95G	1	.	.	283	285	GGC	581	583	GGC	188;187;186	G;G,T;C,A	171;168,1;171,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5680	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3483	162.6	1	SNP	p	G95N	0	.	.	283	285	GGC	581	583	GGC	188;187;186	G;G,T;C,A	171;168,1;171,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1790	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1260	140.8	1	SNP	p	G45D	0	.	.	133	135	GGC	395	397	GGC	215;216;216	G;G;C	190;191;193	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	930	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1062	87.0	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	195	A	184	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1537	1539	GTC	212;210;208	G;T;C	201;196;195	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	1	SNP	p	D86N	0	.	.	256	258	GAC	643	645	GAC	195;195;195	G;A;C,T	182;178;184,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	1	SNP	p	R87W	0	.	.	259	261	CGT	646	648	CGT	195;199;196	C;G;T	184;188;184	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	1	SNP	p	S87R	1	.	.	259	261	CGT	646	648	CGT	195;199;196	C;G;T	184;188;184	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	1	SNP	p	R87I	0	.	.	259	261	CGT	646	648	CGT	195;199;196	C;G;T	184;188;184	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5026	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2938	169.9	1	SNP	p	S88P	0	.	.	262	264	TCC	649	651	TCC	197;196;195	T;C,T;C	188;186,1;184	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4432	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2744	160.4	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1381	1383	TGC	197;196;197	T;G;C	177;176;181	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4432	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2744	160.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1591	1593	GGC	239;236;232	G,C;G;C	215,1;214;205	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1200	1202	GCA	205;206;207	G;C;A	194;194;197	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1203	1205	ATC	207;206;206	A;T,G;C	199;196,1;197	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1215	1217	GTG	208;213;214	G;T;G	200;200;205	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1215	1217	GTG	208;213;214	G;T;G	200;200;205	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1719	1721	ACC	193;193;192	A;C,A;C	174;178,1;179	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1773	1775	GCG	195;196;197	G,A;C,G;G	169,1;151,1;164	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1773	1775	GCG	195;196;197	G,A;C,G;G	169,1;151,1;164	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1896	1898	GGC	158;160;160	G;G;C	149;150;148	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1905	1907	GGC	165;163;162	G;G;C	150;151;146	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3988	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2346	168.8	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1923	1925	TCG	167;168;167	T,G;C;G	116,9;145;141	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6264	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3167	197.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1708	1710	CCG	231;233;231	C;C;G	202;217;208	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2440	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1978	122.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	746	746	C	153	C	144	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	399	401	GAA	233;232;232	G;A;A,T	219;221;219,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	687	689	GAT	230;230;234	G;A;T	214;215;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	810	812	TCA	253;255;260	T;C;A	237;238;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	939	941	GTC	256;255;255	G;T;C	237;240;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1269	1271	GCA	235;237;238	G;C;A	213;217;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	1	SNP	p	G120K	1	.	.	358	360	AAG	645	647	AAG	208;211;214	A;A;G	199;201;202	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	1	SNP	p	A121D	1	.	.	361	363	GAC	648	650	GAC	210;210;210	G;A;C	200;200;198	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2894	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1465	194.3	1	SNP	p	D121N	0	.	.	361	363	GAC	648	650	GAC	210;210;210	G;A;C	200;200;198	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10596	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4906	215.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2118	2120	AAT	216;213;215	A;A;T	207;201;200	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1188	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1052	112.2	1	SNP	p	V57M	1	.	.	169	171	ATG	493	495	ATG	224;226;223	A;T;G	216;218;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
